Summary of the invention:
The present invention adopts beta cyclodextrin or derivatives thereof and levosimendan to form clathrate,, has obtained and has made the levosimendan good stability, the effect that dissolubility is strong as solvent for injection with ethanol.
The invention provides a kind of new levosimendan injection and preparation method thereof.
The present invention also provides the method that increases the levosimendan dissolubility.
Injection of the present invention contains the levosimendan of effective dose, the beta cyclodextrin or derivatives thereof, and injectable ethanol also can add excipient and PH regulator in case of necessity.
Use the cyclodextrin or derivatives thereof that levosimendan is carried out enclose, so that levosimendan is easily molten.As use beta-schardinger dextrin-or HP-.Preferably use HP-(Hydroxypropyl-beta-Cyclodextrin; Be called for short: HP-β-CD or HPB).HP-is safe, nontoxic, stable blood vessel and the medicinal adjuvant of non-blood vessel.
Injection of the present invention, levosimendan and beta-schardinger dextrin-or derivatives thereof form clathrate, and wherein the weight ratio of levosimendan and beta-schardinger dextrin-or derivatives thereof is 1: 1~1: 100.The weight ratio of preferred levosimendan and cyclodextrin or derivatives thereof is 1: 5~1: 30.Mol ratio can be 1: 10, is preferably 1: 5.Above-mentioned clathrate can be as the raw material of injection, powder pin or transfusion.Said injection can be " 1-20ml injection with small volume ", " freeze-dried powder ", " aseptic powder injection " or add in " glucose infusion liquid, sodium chloride transfusion, xylitol transfusion ", " vein emulsion ", " injection ", said " freeze-dried powder " is that levosimendan beta-schardinger dextrin-or derivatives thereof forms in the solution of clathrate and adds suitable excipient, as mannitol, lactose, dextran, sorbitol, sucrose, sodium chloride, xylitol etc., get by lyophilization.Said " aseptic powder injection " is to add suitable excipient in the solution of levosimendan beta-schardinger dextrin-or derivatives thereof formation clathrate, as PH regulator, mannitol, lactose, dextran, sorbitol, glucose, sucrose, sodium chloride, xylitol etc., the powder that obtains by " lyophilization " or " spray drying " carries out aseptic subpackaged getting.
The present invention also provides the preparation method of injection of the present invention, carries out the preparation of the injection of the present invention of enclose for above-mentioned use beta-schardinger dextrin-or derivatives thereof, may further comprise the steps:
A) the beta-schardinger dextrin-or derivatives thereof is placed ethanol, after the stirring and dissolving, add again the levosimendan stirring at room make molten, levosimendan beta-schardinger dextrin-or derivatives thereof inclusion complex in solution,
Can add PH regulator, mannitol, lactose, dextran, sorbitol, sucrose, glucose, sodium chloride, xylitol, injection ethanol when b) gained solution needs as excipient and make it dissolving,
C) solution that in case of necessity step b or step c is obtained is through vacuum drying or spray drying, levosimendan powder-beta-dextrin or derivatives thereof clathrate injection powder,
D) packing.
Injection of the present invention contains the 1-100mg levosimendan, preferably 1-10mg, more preferably 2-5mg in the per unit preparation.
Injection of the present invention, described solvent for injection are injection ethanol, preferably dehydrated alcohol.
Injection of the present invention adds the PH regulator in case of necessity, and described PH regulator is selected from acidic materials, and example hydrochloric acid, citric acid, acetic acid, phosphoric acid etc. are preferably citric acid.
The present invention with levosimendan make host molecule, the beta cyclodextrin or derivatives thereof is made enclosed molecule, the enclosed molecule hydroxypropyl beta cyclodextrin has been carried out following experiment to the solubilizing effect of host molecule levosimendan: concrete steps are: get levosimendan and hydroxypropyl beta cyclodextrin (HP β CD) in molar ratio and be dissolved in the injection dehydrated alcohol, make the PH regulator with citric acid/ammonium carbonate, the investigation hydroxypropyl beta cyclodextrin to the solubilizing effect of levosimendan, the results are shown in Figure 1 under different pH.As can be seen from the results, the dissolubility of levosimendan and pH value of solution, hydroxypropyl beta cyclodextrin amount are relevant.
The checking of Levosimendan hydroxypropyl beta cyclodextrin solubilizing effect:
Prepare its alcoholic solution by Levosimendan hydroxypropyl beta cyclodextrin certain mol proportion, put vacuum drying, get pale yellow powder down to doing; A certain amount of powder is added respectively in ethanol, the water, solution; Above-mentioned solution is put the freezing liquid of crossing of refrigerator, and its alcoholic solution does not have separates out, and its aqueous solution room temperature is placed to fusing, does not have precipitation and separates out.The result shows that hydroxypropyl beta cyclodextrin has carried out enclose to levosimendan.
Levosimendan hydroxypropyl beta cyclodextrin ethanol liquid, Levosimendan KollidonPF12 ethanol liquid, the Levosimendan hydroxypropyl beta cyclodextrin aqueous solution of preparation carries out stability relatively, the results are shown in Table 1:
Table 1 Levosimendan hydroxypropyl beta cyclodextrin ethanol liquid, Levosimendan KollidonPF12 ethanol liquid, Levosimendan hydroxypropyl beta cyclodextrin aqueous solution carry out stability relatively
Room temperature standing time (my god) |
Related substance (%) |
|
Levosimendan HP β CD ethanol |
Levosimendan KollidonPF12 ethanol |
Levosimendan HP β CD aqueous solution |
0 7 14 21 |
0.17 0.17 0.19 0.20 |
0.34 0.36 0.44 0.58 |
0.24 1.23 3.78 6.32 |
The mensuration of related substance is meant the mensuration of the impurity content in the levosimendan, and the result shows that Levosimendan hydroxypropyl beta cyclodextrin ethanol liquid stability of the present invention obviously improves in the table.
Carry out the compatibility test of pharmacological effect, toxicity, stability and preparation, injection safety of the present invention, stable, effective, simple to operate by the injection that Levosimendan hydroxypropyl beta cyclodextrin clathrate of the present invention is made.
The specific embodiment:
Further specify the present invention by the following examples.
Embodiment 1
Levosimendan 2.5mg/ml, hydroxypropyl beta cyclodextrin 50mg/ml, injection ethanol 5ml dissolve injection solution.
Embodiment 2
Levosimendan 2.5mg/ml, hydroxypropyl beta cyclodextrin 50mg/ml, citric acid 2mg/ml, injection ethanol 5ml dissolve injection solution.
Embodiment 3
Levosimendan 2.5mg/ml, hydroxypropyl beta cyclodextrin 50mg/ml, injection ethanol 5ml dissolving, filtration, vacuum drying get Levosimendan hydroxypropyl beta cyclodextrin clathrate dry powder.
Embodiment 4
Levosimendan 2.5mg/ml, hydroxypropyl beta cyclodextrin 50mg/ml, injection ethanol 5ml dissolving, filtration, vacuum drying powder mix to such an extent that Levosimendan hydroxypropyl beta cyclodextrin-mannitol mixes powder with a certain amount of injection mannitol.
Embodiment 5
Levosimendan 2.5mg/ml, hydroxypropyl beta cyclodextrin 50mg/ml, injection ethanol 5ml dissolving, filtration, vacuum drying powder are dissolved in the finite concentration Osmitrol, get Levosimendan hydroxypropyl beta cyclodextrin-mannitol after filtration, the lyophilization and mix powder.